title: [Brain metastases from breast cancer].
abstract: Breast cancer is the second leading cause of brain metastases and account for 15 % of metastatic breast cancer patients. Several patient- and tumor-related characteristics have been identified as risk factors for developing brain metastases. Treatment is based on local and/or systemic therapies, tailored to breast cancer brain metastases-specific prognostic factors. This article is an update on the current knowledge of the incidence, prognosis and prognostic factors, treatment and perspectives in brain metastases from breast cancer.
authors.affiliation: Département d'oncologie radiothérapie, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13009 Marseille cedex 09, France. Electronic address: talleta@ipc.unicancer.fr.
authors.forename: A
authors.initials: A
authors.lastname: Tallet
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy*; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D016371:Cranial Irradiation; D005260:Female; D006801:Humans; D015994:Incidence; D011379:Prognosis; D016634:Radiosurgery
chemical_list: D000970:Antineoplastic Agents
keywords: Brain metastases; Breast cancer; Cancer du sein; Facteurs pronostiques; Métastases cérébrales; Prognostic factors; Traitements; Treatment